Usana Health Sciences (USNA) Cash & Current Investments (2016 - 2025)
Historic Cash & Current Investments for Usana Health Sciences (USNA) over the last 16 years, with Q3 2025 value amounting to $145.3 million.
- Usana Health Sciences' Cash & Current Investments fell 6016.62% to $145.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was $145.3 million, marking a year-over-year decrease of 6016.62%. This contributed to the annual value of $181.8 million for FY2024, which is 4498.88% down from last year.
- Usana Health Sciences' Cash & Current Investments amounted to $145.3 million in Q3 2025, which was down 6016.62% from $151.3 million recorded in Q2 2025.
- In the past 5 years, Usana Health Sciences' Cash & Current Investments ranged from a high of $364.9 million in Q3 2024 and a low of $145.3 million during Q3 2025
- In the last 5 years, Usana Health Sciences' Cash & Current Investments had a median value of $261.2 million in 2021 and averaged $262.2 million.
- Per our database at Business Quant, Usana Health Sciences' Cash & Current Investments surged by 3282.67% in 2021 and then plummeted by 6016.62% in 2025.
- Over the past 5 years, Usana Health Sciences' Cash & Current Investments (Quarter) stood at $248.7 million in 2021, then increased by 15.97% to $288.4 million in 2022, then rose by 14.56% to $330.4 million in 2023, then crashed by 44.99% to $181.8 million in 2024, then dropped by 20.04% to $145.3 million in 2025.
- Its Cash & Current Investments was $145.3 million in Q3 2025, compared to $151.3 million in Q2 2025 and $179.6 million in Q1 2025.